Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. They specialize in the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. With a team of experienced scientists, management, and technicians, Stemedica is dedicated to advancing their proprietary technology, which produces multiple progenitor cell products that meet rigorous quality standards required for a cGMP licensed facility. Stemedica is currently at the forefront of clinical trials in the United States for several critical medical conditions. Their focus lies in ischemic stroke and Alzheimer's disease, among others. As a best-in-class manufacturer of ischemic tolerant stem cells, Stemedica aims to provide innovative solutions and treatments for patients in need. With their commitment to research and development, Stemedica continues to make significant strides in the field of regenerative medicine.Generated from the website

Hot Loan

Jerrah Biotech Inc

Mayer Reprographics

Bio Applied Technologies Joint